News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biologics, Inc. (NC) To Be Exclusive Specialty Pharmacy Provider Of Eli Lilly and Company (LLY)’s CYRAMZA™ (Ramucirumab)



5/6/2014 11:14:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARY, N.C.--(BUSINESS WIRE)--Biologics, an integrated oncology services company, is excited to announce that Eli Lilly has selected its Oncology Pharmacy Services to be the exclusive specialty pharmacy provider of CYRAMZA™ (ramucirumab). In addition to accessing the drug via specialty distribution, Eli Lilly made the decision to offer physicians and healthcare practices the opportunity to order CYRAMZA™ through Biologics as an alternative option.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES